The Transfection Reagents and Equipment Market is driven by increasing research activities in genetics, biotechnology, and pharmaceutical development. The growing adoption of gene therapy and gene-editing technologies is creating significant demand for reliable methods of delivering genetic material into cells.

The expansion of cell and molecular biology research is another important growth factor. Pharmaceutical and biotechnology companies are investing in innovative therapies, vaccines, and biologics, increasing the need for efficient laboratory transfection technologies.

Increasing academic research, growing biotechnology investments, and advances in cell-based assays are expected to further support the development of the market.